Detection of Allergenic Proteins in Foodstuffs: Advantages of the Innovative Multiplex Allergen Microarray-Based Immunoassay Compared to Conventional Methods
- PMID: 35327300
- PMCID: PMC8949930
- DOI: 10.3390/foods11060878
Detection of Allergenic Proteins in Foodstuffs: Advantages of the Innovative Multiplex Allergen Microarray-Based Immunoassay Compared to Conventional Methods
Abstract
Several factors can affect the allergen content and profile of a specific food, including processing procedures often leading to a decrease in allergenicity, although no change, or even an increase, have also been reported. Evaluation of the effectiveness of a processing procedure requires the availability of reliable methodologies to assess the variation in molecules able to induce allergic reactions in the analyzed food. Conventional and innovative strategies and methodologies can be exploited to identify allergenic proteins in foodstuffs. However, depending on the specific purposes, different methods can be used. In this review, we have critically reviewed the advantages of an innovative method, the multiplex allergen microarray-based immunoassay, in the detection of allergens in foodstuffs. In particular, we have analyzed some studies reporting the exploitation of an IgE-binding inhibition assay on multiplex allergen biochips, which has not yet been reviewed in the available literature. Unlike the others, this methodology enables the identification of many allergenic proteins, some of which are still unknown, which are recognized by IgE from allergic patients, with a single test. The examined literature suggests that the inhibition test associated with the multiplex allergen immunoassay is a promising methodology exploitable for the detection of IgE-binding proteins in food samples.
Keywords: FABER test; ISAC test; IgE binding; IgE-binding inhibition; food allergens; multiplex allergen microarray.
Conflict of interest statement
The authors declare no competing financial interests. CAAM and ADL srl did not provide any funding support, materials or equipment, and had no role in the design of the study and in the writing of this review manuscript, or in the decision to publish it.
Figures
References
-
- Pepper A.N., Assa’Ad A., Blaiss M., Brown E., Chinthrajah S., Ciaccio C., Fasano M.B., Gupta R., Hong N., Lang D., et al. Consensus report from the Food Allergy Research & Education (FARE) 2019 Oral Immunotherapy for Food Allergy Summit. J. Allergy Clin. Immunol. 2020;146:244–249. doi: 10.1016/j.jaci.2020.05.027. - DOI - PubMed
-
- Verhoeckx K., Bøgh K.L., Constable A., Epstein M., Sommergruber K.H., Holzhauser T., Houben G., Kuehn A., Roggen E., O’Mahony L., et al. COST Action ‘ImpARAS’: What have we learnt to improve food allergy risk assessment. A summary of a 4 year networking consortium. Clin. Transl. Allergy. 2020;10:13. doi: 10.1186/s13601-020-00318-x. - DOI - PMC - PubMed
-
- Alessandri C., Ferrara R., Bernardi M.L., Zennaro D., Tuppo L., Giangrieco I., Ricciardi T., Tamburrini M., Ciardiello M.A., Mari A. Molecular approach to a patient’s tailored diagnosis of the oral allergy syndrome. Clin. Transl. Allergy. 2020;10:22. doi: 10.1186/s13601-020-00329-8. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
